2017
Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis
Martínez-Valencia AJ, Daza-Rivera CF, Rosales-Chilama M, Cossio A, Rincón E, Desai MM, Saravia NG, Gómez MA. Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis. PLOS Neglected Tropical Diseases 2017, 11: e0005713. PMID: 28704369, PMCID: PMC5526576, DOI: 10.1371/journal.pntd.0005713.Peer-Reviewed Original ResearchConceptsCutaneous leishmaniasisParasite persistencePercent of patientsInitiation of treatmentEnd of treatmentViability of LeishmaniaDisease reactivationTonsillar mucosaClinical cureClinical resolutionTreatment initiationProtective immunityMeglumine antimoniatePersistent infectionMucosal tissuesPrevious episodesTherapeutic cureParasitological factorsProtective factorsPatientsParasitological parametersTreatmentLeishmaniasisWeeksHigher proportion
2010
Viability and Burden of Leishmania in Extralesional Sites during Human Dermal Leishmaniasis
Romero I, Téllez J, Suárez Y, Cardona M, Figueroa R, Zelazny A, Saravia N. Viability and Burden of Leishmania in Extralesional Sites during Human Dermal Leishmaniasis. PLOS Neglected Tropical Diseases 2010, 4: e819. PMID: 20856851, PMCID: PMC2939031, DOI: 10.1371/journal.pntd.0000819.Peer-Reviewed Original ResearchConceptsLeishmaniasis patientsExtralesional sitesNormal skinTonsil swabsViable parasitesDissemination of LeishmaniaMucocutaneous leishmaniasis patientsMonocyte samplesPositive samplesLuciferase activityParasite viabilitySkin aspiratesActive diseaseDermal leishmaniasisHuman leishmaniasisBlood monocytesEpidemiologic investigationsPatientsLeishmania DNAParasite burdenHuman infectionsIntracellular amastigotesLesionsSwabsEpidemiological significance